ICD-10-CM Billable Code

E72.54

Secondary hyperoxaluria

Clinical Classification Guidelines

Excludes Type 1

  • primary hyperoxaluria (E72.53-)

Medical Intelligence & Overview

Secondary hyperoxaluria is a medical condition characterized by an excessive accumulation of oxalate in the body, which can lead to the formation of kidney stones and other complications. Unlike primary hyperoxaluria, which is caused by genetic factors, secondary hyperoxaluria results from external influences such as diet, certain medical conditions, or medication use. Recognizing the causes and symptoms of this condition is essential for managing its impact on health effectively.

Causes & Symptoms

Clinical Causes: High dietary intake of oxalate-rich foods such as spinach, nuts, and tea Malabsorption syndromes like Crohn's disease or celiac disease that lead to increased oxalate absorption Excessive intake or supplementation with vitamin C, which can be metabolized into oxalate Certain medical conditions that impair kidney function, reducing oxalate excretion Use of medications that increase oxalate production or decrease its clearance, such as some antibiotics or orlistat

Key Symptoms: Repeated episodes of kidney stones, often causing severe pain Hematuria, or blood in the urine Frequent urinary tract infections Lower back or flank pain Urinary urgency or discomfort In rare cases, signs of kidney damage or decreased kidney function such as swelling, fatigue, or high blood pressure

Diagnostic & Treatment

Diagnosis Path: Diagnosing secondary hyperoxaluria involves a combination of medical history, physical examination, and laboratory tests. Urinalysis can detect elevated oxalate levels in the urine, while blood tests assess kidney function. Additionally, 24-hour urine collection may be performed to evaluate oxalate excretion over a full day. Imaging studies like ultrasound or CT scans are used to identify kidney stones or other renal abnormalities. In some cases, doctors may recommend genetic testing to rule out primary hyperoxaluria, ensuring that the hyperoxaluria is secondary to external factors.

Treatment Protocols: Managing secondary hyperoxaluria primarily focuses on addressing its underlying causes and minimizing oxalate accumulation. Dietary modifications include reducing intake of high-oxalate foods and ensuring adequate calcium intake to bind dietary oxalate in the gut. Treatment may involve medications such as citrate to prevent stone formation or diuretics to enhance oxalate excretion. For individuals with malabsorption issues, nutritional support and treatment of the underlying condition are vital. In cases of significant kidney damage or recurrent stones, surgical intervention might be recommended. Regular monitoring of urine oxalate levels and kidney function are essential components of ongoing care.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E72.54 a billable ICD-10 code?
Yes, E72.54 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E72.54?
Clinical documentation must specify the nature of Secondary hyperoxaluria and any associated comorbidities for accurate reporting.

Cite this Clinical Reference